Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CATCH: aPTT vs Anti-Xa Monitoring for Unfractionated Heparin
NCT03426982Phase 4Unknown
- Sponsor
- Wuhan Asia Heart Hospital
- Start
- Mar 2018
- Primary completion
- Oct 2018
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of heparin in venous thromboembolism (VTE), acute coronary syndrome (ACS), sponsored by Wuhan Asia Heart Hospital. Status: unknown.
02
Drugs
heparin
03
Conditions
venous thromboembolism (VTE)acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT03426982.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03426982.